Date: 2016-06-06
Type of information: Nomination
Compound:
Company: Alder Biopharmaceuticals (USA - WA)
Therapeutic area: CNS diseases - Neurological diseases
Type agreement: nomination
Action mechanism:
Disease:
Details: • On June 6, 2016, Alder BioPharmaceuticals announced the appointment of Roger K. Cady, M.D. as vice president of neurology. Since 1995, Dr. Cady has served as the medical director of the Headache Care Center and was the founder of Clinvest and Primary Care Network located in Springfield, Mo. From 1986 to 1995, he was the medical director for the Shealy Institute in Springfield, Mo. Earlier in his career he had a family practice in Hillsboro, Wis. Dr. Cady holds a bachelor's degree from Drake University in Des Moines, Iowa, and a medical degree from the Mayo Medical School in Rochester, Minn. He completed his residency in family practice at St. Francis Mayo in LaCrosse, Wis. Dr. Cady is a fellow of the American Headache Society and a member of the board of directors for the National Headache Foundation. He is the co-recipient of the Harold Wolff Award in 2000 for his research on the spectrum of primary headache in migraine sufferers. He was awarded the Lifetime Achievement Award by the National Headache Foundation in 2012 and has authored over 200 scientific papers on migraine diagnosis, pathophysiology, and treatment. Dr. Cady has participated in over 300 clinical trials, and designed and conducted investigator initiated studies, which evaluated numerous migraine therapies and have been instrumental in defining the early intervention paradigm for migraine treatment, clarifying the relationship between migraine and sinus headache, and improving communication between patients and healthcare providers.
Financial terms:
Latest news:
